However, especially in the luminal B subtype (Fig. 2), xenografted tumors tended to lose ER expression, which may be due to tumor heterogeneity in the primary human tumor, resulting in better “take rates” in mice for the ER negative subclones. The gene discussed is ESR1; the disease is neoplasm.